Analysis of external dose rate attenuation and its related factors in differentiated thyroid carcinoma patients following I-131 therapy.

No abstract is available for this paper.

• Publication year

  2026

• Venue

  EJNMMI Physics

• Publication date

  2026-02-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1186/s40658-026-00845-9PMID 41655156PMCID PMC12988089
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Advantages and Limitations of the Body Mass Index (BMI) to Assess Adult Obesity

  2024cited by this paper
• Cancer incidence and mortality in China, 2022

  2024cited by this paper
• Epidemiology of Thyroid Cancer.

  2022cited by this paper
• Transcriptional Expressions of ALDH1A1/B1 as Independent Indicators for the Survival of Thyroid Cancer Patients

  2022cited by this paper
• Management of Differentiated Thyroid Cancer: The Standard of Care

  2021cited by this paper
• Predictive Value of a Thyroid-Absorbed Dose with a Shorter Effective Half-Life on Efficacy in Graves Disease Patients Receiving Iodine-131 Therapy

  2020cited by this paper
• Analysis of Radiometry on Patients Undergoing Radioactive Iodine Therapy

  2020cited by this paper
• Metabolic Syndrome and the Risk of Thyroid Cancer: A Nationwide Population-Based Cohort Study

  2020cited by this paper
• Gender differences in estimating I-131 thyroid uptake from Tc-99m thyroid uptake for benign thyroid disease.

  2020cited by this paper
• Radiation Monitoring of an Isolation Room for 131I Therapy After the Patients Were Released.

  2019cited by this paper
• European Perspective on 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: Proceedings of an Interactive International Symposium

  2019cited by this paper
• Radioactive Iodine Therapy in Patients with Differentiated Thyroid Cancer: Study of External Dose Rate Attenuation Law and Individualized Patient Management

  2019cited by this paper
• Impact of smoking on thyroid gland: dose-related effect of urinary cotinine levels on thyroid function and thyroid autoimmunity

  2019cited by this paper
• Differentiated thyroid cancer theranostics: radioiodine and beyond.

  2018cited by this paper
• Association of obesity and diabetes with thyroid nodules

  2018cited by this paper
• Radiation dose rates of differentiated thyroid cancer patients after 131I therapy

  2018cited by this paper
• Higher body weight and distant metastasis are associated with higher radiation exposure to the household environment from patients with thyroid cancer after radioactive iodine therapy

  2017cited by this paper
• Iodine-131: An Effective Method for Treating Lymph Node Metastases of Differentiated Thyroid Cancer

  2016cited by this paper
• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

  2015cited by this paper
• Optimal Differentiated Thyroid Cancer Management in the Elderly

  2015cited by this paper
• Aggressive Variants of Papillary Thyroid Cancer: Incidence, Characteristics and Predictors of Survival among 43,738 Patients

  2012cited by this paper
• 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

  2009cited by this paper
• Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China

  2007cited by this paper
• Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.

  2006cited by this paper
• Diagnostic value of serum thyroglobulin measurements in the follow‐up of differentiated thyroid carcinoma, a structured meta‐analysis

  2004cited by this paper
• Release of patients after therapy with unsealed radionuclides

  2004cited by this paper
• A practical methodology for patient release after tositumomab and (131)I-tositumomab therapy.

  2002cited by this paper
• Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid

  1997cited by this paper
• Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid

  1996cited by this paper
• Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients.

  1981cited by this paper

• No citing papers are available for this paper.